Dr. Iacopo Olivotto, trained in Florence and London, has pursued a career in Emergency Medicine and subsequently in Cardiology at Careggi University Hospital in Florence, Italy, where he currently serves as Director of the Cardiomyopathy Unit.
Over more than two decades, Dr. Olivotto's main clinical and research interests have includes various aspects of cardiomyopathies, with special focus on hypertrophic cardiomyopathy (HCM), ranging from clinical predictors of disease progression and outcome, arrhythmias, characterization of the end-stage phase, medical and surgical management, imaging studies of coronary flow reserve with PET, functional and prognostic relevance of magnetic resonance studies, echocardiographic screening and early HCM diagnosis, studies of pre-hypertrophic phenotype, genetic studies addressing the prevalence and characterization of HCM-causing mutations, genotype-phenotype correlations, family studies, developmental aspects of HCM, molecular studies of myofilament contractility, correlation of in-vitro findings with clinical and echocardiographic variables. These lines of research are being carried out in cooperation with a rapidly growing multidisciplinary team in Florence, as well as distinguished Institutions in Europe and the US. He is a co-founder of the ShaRe International Registry for Cardiomyopathies (www.theshareregistry.org) and the promoter of several international symposia on genetic heart diseases.
Recently, he has been involved in promoting randomized trials in cardiomyopathies based on translational approaches to the core pathophysiological mechanisms of disease. Dr. Olivotto has co-authored over 150 papers in peer-reviewed journals, and serves as reviewer for the main international cardiovascular journals.
He is an active member of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.